Blood, a crucial resource for cancer treatment, is readily available with its components separated as required.
History:
The introduction of Blood Component therapy, aided by the blood cell separator, marked a milestone in supportive high-dose Chemotherapy treatment in India in 1978. In 2003, a blood gamma irradiator was established. A significant leap occurred in 2016 with the adoption of Chemiluminescence testing for transfusion-transmissible infections like HIV, HBV, and HCV. Subsequent years saw the implementation of various enhancements, including walk-in cold storage rooms for blood components (2019), automation for Immuno-haematology testing (2019), installation of a chute system for blood samples and components transport (2019), and the inauguration of a blood donation drive vehicle (2019).
Mission
Our mission is to elevate patient well-being and preserve lives through the provision of the safest blood supply, offering suitable therapeutic Apheresis services, and fostering research and educational initiatives in transfusion medicine. Our aspiration is to achieve 100 percent voluntary blood donation, eliminating the need for replacement donors. We are committed to promoting judicious clinical utilization of blood and its components, guaranteeing a reliable supply of secure blood and associated products whenever and wherever they are required.
Vision:
Committed to quality, integrity, service, and excellence, our vision encompasses all our endeavors.
List of Services Provided:
- Donor Counselling and Motivation.
- Donor screening, recruitment, and retention.
- Blood collection from voluntary/replacement donors under aseptic conditions.
- Preparation of blood components, processing, storage at appropriate temperatures, compatibility testing, and distribution of blood components.
- Testing of donated blood – Screening for infectious diseases (HBsAg, Anti-HCV, HIV-Ag-Ab, Syphilis, and Malaria), determining Blood Group and Type, testing for unexpected antibodies.
- Provision for quarantining blood components in a designated location pending retesting of questionable serological results.
- Labelling of blood components according to regulatory standards.
- Rational use of blood and blood components.
- Irradiation of blood components with proper labelling.
- Issuing blood components to intended patients for transfusion.
- Patient Blood grouping & Rh typing, HBsAg, Anti-HCV, HIV-Ag-Ab screening, Coombs test, and antibody titration.
- Discarding blood components not suitable for therapeutic purposes as per BMW guidelines.
- Disposal of consumables and reagents used during collection, processing, and compatibility testing of blood components as per BMW guidelines.
- Performing therapeutic phlebotomy in indicated patients.
- Apheresis procedures – Single Donor Platelets, Granulocyte collection, Peripheral Blood stem cell collection (donors & patients), Therapeutic Plasma pheresis, Therapeutic Leucoreduction, Donor Lymphocyte collection, Therapeutic Platelet Reduction, and Therapeutic plasma exchange.
- Autologous blood collection in indicated patients.